Who Exports Metformin from India — 528 Suppliers Behind a $466.4M Market
India's metformin export market is supplied by 528 active exporters who collectively shipped $466.4M across 15,000 shipments. GRANULES INDIA LIMITED leads with a 32.7% market share, followed by MEDEOR LIFE CARE LLP and INVENTIA HEALTHCARE LIMITED. The top 5 suppliers together control 55.9% of total export value, reflecting a moderately competitive market structure.
Top Metformin Exporters from India — Ranked by Export Value
GRANULES INDIA LIMITED is the leading metformin exporter from India, holding a 32.7% share of the $466.4M market across 15,000 shipments from 528 exporters. The top 5 suppliers — GRANULES INDIA LIMITED, MEDEOR LIFE CARE LLP, INVENTIA HEALTHCARE LIMITED, IPCA LABORATORIES LIMITED, ZENTIVA PRIVATE LIMITED — collectively control 55.9% of total export value, indicating a moderately concentrated market. Individual shares are: GRANULES INDIA LIMITED (32.7%), MEDEOR LIFE CARE LLP (9.7%), INVENTIA HEALTHCARE LIMITED (5.0%), IPCA LABORATORIES LIMITED (4.4%), ZENTIVA PRIVATE LIMITED (4.2%).
Top Metformin Exporters from India
Ranked by export value · 528 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | GRANULES INDIA LIMITED PHARMACEUTICAL PRODUCTS - METFORMIN LICHMETFORMIN 1000MG TABLETSMETFORMIN HYDROCHLORIDE TABLETS USP 1000 | $152.5M | 19 | 32.7% |
| 2 | MEDEOR LIFE CARE LLP DIABZID M (METFORMIN HYDROCHLORIDE 500 MDIABZID MDIABZID MNOS | $45.1M | 1 | 9.7% |
| 3 | INVENTIA HEALTHCARE LIMITED NORMAX (METFORMIN HYDROCHLORIDE EXTENDEDMETFORMIN HYDROCHLORIDE TABLETS USP 1000MACLOGLYMIN 850 1X84S | $23.1M | 16 | 5.0% |
| 4 | IPCA LABORATORIES LIMITED METFORMIN 1000MG TABLETSNORMAX (METFORMIN HYDROCHLORIDE EXTENDEDMETFORMIN HYDROCHLORIDE TABLETS USP 1000 | $20.7M | 14 | 4.4% |
| 5 | ZENTIVA PRIVATE LIMITED PHARMACEUTICAL PRODUCTS - METFORMIN LICHMETFORMIN 1000MG TABLETSINDIAN HARMLESS MEDICINES - METFORMIN HY | $19.4M | 5 | 4.2% |
| 6 | AUROBINDO PHARMA LTD METFORMIN 1000MG TABLETSMETFORMIN HYDROCHLORIDE TABLETS USP 1000METFORMIN 1000 MG TABLETS(METFORMINA AUR | $16.6M | 9 | 3.6% |
| 7 | MICRO LABS LIMITED METFORMIN 1000MG TABLETSNORMAX (METFORMIN HYDROCHLORIDE EXTENDEDMETFORMIN HYDROCHLORIDE TABLETS USP 1000 | $16.2M | 31 | 3.5% |
| 8 | ALKEM LABORATORIES LIMITED METFORMIN HYDROCHLORIDE TABLETS USP 1000METFORMIN HYDROCHLORIDE TABLETS USP 500MMETEX XR (METFORMIN HYDROCHLORIDE PROLON | $13.3M | 4 | 2.8% |
| 9 | ZYDUS LIFESCIENCES LIMITED METFORMIN 1000MG TABLETSNORMAX (METFORMIN HYDROCHLORIDE EXTENDEDMETFORMIN HYDROCHLORIDE TABLETS USP 1000 | $9.8M | 8 | 2.1% |
| 10 | USV PRIVATE LIMITED NORMAX (METFORMIN HYDROCHLORIDE EXTENDEDMETFORMIN HYDROCHLORIDE TABLETS USP 1000INDIAN HARMLESS MEDICINES - METFORMIN HY | $9.2M | 7 | 2.0% |
| 11 | MEDREICH LIMITED METEX XR (METFORMIN HYDROCHLORIDE PROLONMETFORMIN HCL 500MG TABLETSMETEX XR METFORMIN HYDROCHLORIDE PROLON | $7.3M | 6 | 1.6% |
| 12 | FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED METFORMIN HCL 500MG TABLETSSUKKARTO SR 10SUKKARTO SR METFORMIN HYDROCHLORIDE 50 | $7.1M | 12 | 1.5% |
| 13 | CENTAUR PHARMACEUTICALS PRIVATE LIMITED METFORMIN 1000MG TABLETSMACLOGLYMIN 850 1X84SINDIAN HARMLESS MEDICINES - METFORMIN HY | $7.1M | 5 | 1.5% |
| 14 | AUROBINDO PHARMA LIMITED METFORMIN 1000MG TABLETSMETFORMIN HYDROCHLORIDE TABLETS USP 1000METFORMIN 1000 MG TABLETS(METFORMINA AUR | $7.0M | 9 | 1.5% |
| 15 | HARMAN FINOCHEM LIMITED METFORMIN HYDROCHLORIDE TABLETS USP 1000METFORMIN 1000 MG TABLETS(METFORMINA AURINDIAN HARMLESS MEDICINES - METFORMIN HY | $6.9M | 6 | 1.5% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Metformin exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Aurobindo Pharma Limited | Approved | Yes | Yes | Multiple | FDA approval for various drugs; WHO-GMP and EU GMP certified; received FDA warni |
| Zydus Lifesciences Limited | Approved | Yes | Yes | Multiple | FDA approval for various drugs; WHO-GMP and EU GMP certified; no FDA warning let |
| Fourrts (India) Laboratories Private Limited | Not Listed | Yes | Yes | Not Listed | WHO-GMP and EU GMP certified; no FDA approval or warning letters. |
| Granules India Limited | Approved | Yes | Yes | Multiple | FDA approval for various drugs; WHO-GMP and EU GMP certified; no FDA warning let |
| Inventia Healthcare Limited | Approved | Yes | Yes | Multiple | FDA approval for various drugs; WHO-GMP and EU GMP certified; no FDA warning let |
| Ipca Laboratories Limited | Approved | Yes | Yes | Multiple | FDA approval for various drugs; WHO-GMP and EU GMP certified; no FDA warning let |
| Micro Labs Limited | Approved | Yes | Yes | Multiple | FDA approval for various drugs; WHO-GMP and EU GMP certified; no FDA warning let |
| Alkem Laboratories Limited | Approved | Yes | Yes | Multiple | FDA approval for various drugs; WHO-GMP and EU GMP certified; no FDA warning let |
| USV Private Limited | Approved | Yes | Yes | Multiple | FDA approval for various drugs; WHO-GMP and EU GMP certified; no FDA warning let |
| Medreich Limited | Approved | Yes | Yes | Multiple | FDA approval for various drugs; WHO-GMP and EU GMP certified; no FDA warning let |
TransData Nexus reviewed the regulatory standing of 10 leading Metformin exporters from India. 9 hold US FDA facility approvals, 10 maintain WHO-GMP certification, and 10 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Metformin sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% of the country's bulk drug production. The city hosts numerous pharmaceutical companies specializing in active pharmaceutical ingredients (APIs) and bulk drugs. Notably, Granules India Limited, the leading exporter of Metformin, is headquartered here. The presence of specialized firms like A.R. Life Sciences, which manufactures both intermediates and APIs, underscores Hyderabad's pivotal role in the pharmaceutical supply chain.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations. Vadodara, in particular, is home to Alembic Pharmaceuticals, a company with a significant presence in the Metformin market. The region's pharmaceutical industry benefits from a robust infrastructure and a skilled workforce, making it a key player in the production of finished pharmaceutical products.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for pharmaceutical products. Companies like Inventia Healthcare Limited, a top exporter of Metformin, operate in this region. The area's strategic location, coupled with well-established port facilities, facilitates efficient international distribution of pharmaceutical products.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a pharmaceutical manufacturing hub, largely due to favorable tax incentives. This zone attracts numerous pharmaceutical companies seeking cost-effective production solutions, thereby contributing to the overall supply chain of drugs like Metformin.
5Sourcing Recommendations
- Diversify Supplier Base: To mitigate risks associated with over-reliance on a few suppliers, consider engaging with multiple manufacturers across different regions.
- Evaluate Supplier Capabilities: Assess potential suppliers' production capacities, quality control measures, and compliance with international standards to ensure consistent product quality.
- Leverage Regional Strengths: Utilize Hyderabad for bulk drug sourcing, Ahmedabad-Vadodara for formulations, and Mumbai-Thane-Raigad for export logistics to optimize the supply chain.
- Monitor Regulatory Compliance: Ensure all suppliers adhere to the regulations set forth by authorities such as the Central Drugs Standard Control Organisation (CDSCO) and the Directorate General of Foreign Trade (DGFT) to maintain compliance and product integrity.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Metformin exporters from India
Granules India Limited — Granules India acquires Senn Chemicals to enhance peptide and CDMO capabilities
Granules India Limited announced the successful acquisition of Senn Chemicals AG, a Swiss-based Contract Development and Manufacturing Organization (CDMO) specializing in peptide development and manufacturing. This strategic move aims to strengthen Granules' position in the peptide therapeutics segment and expand its CDMO services. - IMPACT: The acquisition is expected to diversify Granules India's product portfolio, potentially influencing its focus on Metformin exports.
Impact: The acquisition is expected to diversify Granules India's product portfolio, potentially influencing its focus on Metformin exports.
Granules India Limited — Granules India enters peptide segment with Senn Chemicals acquisition
Granules India Limited signed an acquisition agreement to acquire Senn Chemicals AG, marking its entry into the high-growth peptide therapeutics and CDMO business. The acquisition is subject to certain conditions and is expected to close in the first half of 2025. - IMPACT: This strategic expansion may lead to a reallocation of resources, potentially affecting Metformin production and export volumes.
Impact: This strategic expansion may lead to a reallocation of resources, potentially affecting Metformin production and export volumes.
Inventia Healthcare Limited — Inventia Healthcare to merge with FLCN Healthcare India
The National Company Law Tribunal, Mumbai Bench, directed the convening of a meeting of unsecured creditors to consider the proposed amalgamation of FLCN Healthcare India Private Limited with Inventia Healthcare Limited. The scheme aims to consolidate operations and enhance business synergies. - IMPACT: The merger is anticipated to streamline operations, which could lead to increased efficiency in Metformin production and exports.
Impact: The merger is anticipated to streamline operations, which could lead to increased efficiency in Metformin production and exports.
Common Questions — Metformin Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which metformin supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, GRANULES INDIA LIMITED leads with 2,278 recorded shipments worth $152.5M. MEDEOR LIFE CARE LLP (73 shipments) and INVENTIA HEALTHCARE LIMITED (329 shipments) are also established high-volume exporters.
Q How many metformin manufacturers are there in India?
India has 528 active metformin exporters with a combined export market of $466.4M across 15,000 shipments to 160 countries. The top 5 suppliers hold 55.9% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for metformin from India?
Average FOB unit price: $60.65 per unit, ranging from $0.00 to $21062.67. Average shipment value: $31.1K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 528 verified Indian exporters of Metformin ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 15,000 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 160 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
15,000 Verified Shipments
528 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists